ARGATROBAN

Generic: ARGATROBAN

Amneal Pharmaceuticals LLCManufacturer
INTRAVENOUSRoute
ARGATROBANActive Substance
2018-01-26Original Approval

ARGATROBAN is FDA application ANDA206698, sponsored by AMNEAL PHARMS CO. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Recalls

Top Reported Reactions

1
HEPARIN-INDUCED THROMBOCYTOPENIA
191 reports
2
DRUG INEFFECTIVE
157 reports
3
INTERNATIONAL NORMALISED RATIO INCREASED
110 reports
4
OFF LABEL USE
99 reports
5
ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED
83 reports
6
HAEMORRHAGE
81 reports
7
PULMONARY EMBOLISM
70 reports
8
THROMBOCYTOPENIA
70 reports
9
DEEP VEIN THROMBOSIS
69 reports
10
COAGULATION TIME PROLONGED
64 reports